Switch from calcineurin inhibitors to belatacept in kidney transplant patients with chronic-active antibody mediated rejection results in lower decline in kidney function at three years

Affiliations

• ¹ Nephrology, Kidney Transplant Unit, Rouen University Hospital, 76031, Rouen, France. tristan.de-nattes@chu-rouen.fr.
• ² Department of Immunology, and biotherapies, Normandie University, UNIROUEN, INSERM U1234, Rouen University Hospital, 76031, Rouen, France. tristan.de-nattes@chu-rouen.fr.
• ³ Pathology Department, Rouen University Hospital, 76031, Rouen, France.
• ⁴ Department of Immunology, and biotherapies, Normandie University, UNIROUEN, INSERM U1234, Rouen University Hospital, 76031, Rouen, France.
• ⁵ Nephrology, Kidney Transplant Unit, Rouen University Hospital, 76031, Rouen, France.
• ⁶ Nephrology and Renal Transplantation Department, AP-HP (Assistance Publique-Hôpitaux de Paris), Hôpitaux Universitaires Henri Mondor, F-94010 Créteil, Créteil, France.
• ⁷ Université Paris-Est Créteil, Institut National de la Santé et de la Recherche Médicale (INSERM) U955, Institut Mondor de Recherche Biomédicale (IMRB), F-94010 Créteil, Créteil, France.
• ⁸ Nephrology, Hemodialysis, Apheresis, and Kidney Transplantation Department, University Hospital of Grenoble-Alpes, Grenoble, France.
• ⁹ Nephrology, Hemodialysis, Kidney Transplant Department, Angers University Hospital, 49000, Angers, France.